19
Modeling of Acute Resistance to the HER2 Inhibitor, Lapatinib, in Breast Cancer Cells Marc Fink & Yan Liu & Shangying Wang Student Project Proposal Computational Cell Biology 2012

Modeling of Acute R esistance to the HER2 Inhibitor , L apatinib , in Breast C ancer C ells

  • Upload
    reilly

  • View
    24

  • Download
    0

Embed Size (px)

DESCRIPTION

Modeling of Acute R esistance to the HER2 Inhibitor , L apatinib , in Breast C ancer C ells. Marc Fink & Yan Liu & Shangying Wang Student Project Proposal Computational Cell Biology 2012. Outline. Brief review of the project goal Boolean network model and results - PowerPoint PPT Presentation

Citation preview

Page 1: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Modeling of Acute Resistance to the HER2 Inhibitor, Lapatinib, in

Breast Cancer Cells

Marc Fink & Yan Liu & Shangying WangStudent Project Proposal

Computational Cell Biology 2012

Page 2: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

OutlineBrief review of the project goalBoolean network model and resultsModeling with ODEs in VCell and COPASIAnalysis of cell survival rateSummary and outlook

Page 3: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Goals- Modeling the signaling pathway of HER2 inhibitor,

Lapatinib, in Breast Cancer Cells

- Analyze the influence factors of cell apoptosis

- Explanation of cell survival rate after treatment

01/13

Page 4: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Mechanistic (process) diagrams

HER2

PDK1

AKT (PKB)

14-3-3FoxOFoxO

PI3K

p

pp

p Translocation

FoxOFoxO Apoptotic genes

Transcription

Translocation

ProteinTranslation

FoxOFoxO Survival genes

DeathSurvival

??????

ER

Lapatinib

Apoptosis

02/13

Page 5: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Flow chart and strategies Lack of experimental

parameters => Boolean network

Better understanding of dynamics => ODEs

Analysis of survival rate => Stochastic simulation

03/13

LapatinibHER2 IGF1R

FASL

AKT

FoxO

apoptosis

RAF

MEK

ERK

RSK

BADBIM

Page 6: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Boolean network model

=> Average value of apoptosis is around 0.5 with simplification.

HER2

AKT

FoxO

apoptosis

BIMAp

opto

sisTime steps

04/13

Lapatinib IGF1R

Page 7: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Boolean network modelHER2

FASL

AKT

FoxO

apoptosis

BIM => Average apoptosis is around 0.6 with additional information.

Apop

tosis

Time steps

04/13

Lapatinib IGF1R

Page 8: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Boolean network modelHER2

FASL

AKT

FoxO

apoptosis

RAF

MEK

ERK

RSK

BADBIM => Results depend on

the complexity, adding weights not possible.

Apop

tosis

Time steps

04/13

Lapatinib IGF1R

Page 9: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Modeling with ODEs

=> 22 species and 32 reactions, reasonable rates???!!! 05/13

Page 10: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Model reduction and modification

LapatinibHER2

AKT

FoxO

Due to the importance of FOXO => Neglect the downstream and add the self regulation

Apoptosis

Page 11: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Self regulation of FOXO

FoxO_gene FoxO_mRNA (x) FoxO (y) FoxO* (z)Φ Φ

06/13=> Bistability of the positive feedback loop

Page 12: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Modified model

=> 14 species and 16 reactions 07/13

Page 13: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Sensitivity analysis

=> Laptinib is important for cancer cell apoptosis 08/13

Binding of Laptinib to HER2

FOXODimerization of HER2

Page 14: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Modeling with ODEs IVDeterministic simulations with parameter scan (Laptinib)

=> Laptinib is able to stimulate FOXO, crucial to apoptosis 09/13

Page 15: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Analysis of cell survival rateRandom initial concentrations (with COPASI)

=> Laptinib is able to stimulate cancer cell apoptosis 10/13

Page 16: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Analysis of cell survival rateStochastic simulation (with VCell and C)

=> Laptinib is able to stimulate cancer cell apoptosis 11/13

Page 17: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Summary and outlookApoptosis pathway of breast cancer cell is modeled

and analyzed with simplificationsSurvival rate of cancer cell is analyzed Laptinib induced cancer cell apoptosis is with

certain probabilityOutlookImprove the pathway model with more details by

getting more rates from experimentsValidation of the model and survival rate

12/13

Page 18: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Experience with the softwares COPASI vs VCell Writing reactions + +++Checking parameters + +++Deterministic simulation +++ +Stochastic simulation ++ + Parameter scan +++ ++Sensitivity analysis +++ -Visualization - +++

13/13

Page 19: Modeling of Acute  R esistance  to the HER2  Inhibitor ,  L apatinib , in  Breast  C ancer  C ells

Thank you for your attention!